www.tilray.com Open in urlscan Pro
107.162.234.162  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Brands
Tilray Medical
Adult-Use Brands
Craft-Beverage Brands
Tilray Wellness
Tilray Australia & New Zealand
Tilray Europe
Tilray Latin America
Investors
Leadership
Management
WeCare-MedicalCannabis
Portugal
Germany
France
Take Back Control
CSR
Newsroom
Company News
Tilray In The Press
Careers
Contact


TLRY
NASDAQ:TLRY

TLRY
TSX:TLRY




Brands
Tilray Medical
Adult-Use Brands
Craft-Beverage Brands
Tilray Wellness
Tilray Australia & New Zealand
Tilray Europe
Tilray Latin America
Investors
Leadership
Management
WeCare-MedicalCannabis
Portugal
Germany
France
Take Back Control
CSR
Newsroom
Company News
Tilray In The Press
Careers
Contact
Brands
Tilray Medical
Adult-Use Brands
Craft-Beverage Brands
Tilray Wellness
Tilray Australia & New Zealand
Tilray Europe
Tilray Latin America
Investors
Leadership
Management
WeCare-MedicalCannabis
Portugal
Germany
France
Take Back Control
CSR
Newsroom
Company News
Tilray In The Press
Careers
Contact

Tilray Brands, Inc.






TILRAY: A GLOBAL LEADER

 

Tilray is a global leader in cannabis research, cultivation, processing and
distribution. We aspire to lead, legitimize and define the future of our
industry by building the world’s most trusted cannabis and hemp company.

A proud pioneer, we are the first GMP-certified medical cannabis producer to
supply cannabis flower and extract products to tens of thousands of patients,
physicians, pharmacies, hospitals, governments and researchers on five
continents.




EXPERIENCE




TILRAY'S EXPERIENCE IS UNMATCHED WORLDWIDE. OUR TEAM OF PROFESSIONALS ON THE
GROUND IN 7 COUNTRIES SERVES TENS OF THOUSANDS OF PATIENTS AND CONSUMERS AROUND
THE GLOBE. OUR GMP-CERTIFIED CULTIVATION AND PRODUCTION FACILITIES ARE AMONG THE
MOST ADVANCED IN THE WORLD.




PRECISION




TILRAY IS THE FIRST GMP-CERTIFIED MEDICAL CANNABIS PRODUCER TO SUPPLY CANNABIS
FLOWER AND EXTRACTS. ALL OF OUR PRODUCTS ARE PRODUCED WITH METICULOUS CARE TO
ENSURE THE HIGHEST QUALITY, CONSISTENCY AND PURITY FOR OUR PATIENTS AROUND THE
WORLD.




RESEARCH




WE ARE COMMITTED TO SCIENTIFIC RESEARCH THAT LEADS TO AN IMPROVED QUALITY OF
LIFE FOR PATIENTS IN A TIME FRAME THAT MATTERS. WE PARTNER WITH LEADING
HOSPITALS AND UNIVERSITIES TO ADVANCE THE CLINICAL APPLICATIONS OF CANNABINOIDS.


CARE




TILRAY TAKES TREMENDOUS PRIDE IN OUR CUSTOMER SERVICE, PATIENT OUTREACH, AND
PHYSICIAN INTERACTION. WE RECOGNIZE THE IMPORTANCE OF TRACKING POTENTIAL ADVERSE
EVENTS AS WELL AS THERAPEUTIC BENEFITS IN ORDER TO ENSURE THE SAFETY OF OUR
PATIENTS.




PRECISELY FORMULATED PRODUCTS

Tilray cultivates a wide range of strains to meet patient needs including
indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available
in two primary forms: extracts and dried flower. Each can be administered or
consumed via a variety of methods.

We take a scientific approach to product development. Our product line focuses
on active ingredients and standardized, well-defined preparations. We use
formulations and delivery formats that are intended to allow for consistent and
measured dosing, and we test all of our products for potency and purity. Each of
our commercial products are developed with comprehensive analysis and thorough
documentation, including stability profiles, certificates of analysis,
monographs and drug master files. 


 



ADVANCING CANNABINOID SCIENCE

For the therapeutic value and risks of cannabinoid-based medicines to be fully
understood, Tilray believes it is critical to evolve current scientific
understanding of the field. Our clinical research program is designed with that
in mind. 

Participation in clinical trials is a differentiating element of our research
and development program. We have developed techniques that achieve clinical
grade isolates in order to facilitate participation in clinical trials conducted
by select research partners at world-leading hospitals and universities. 


PRODUCTION PROCESS

Tilray choreographs a complex series of cutting-edge processes to deliver
unparalleled product to its patients. From cultivation to shipping, Tilray's
team brings precision, professionalism and care to each stage of the process.




GLOBAL REACH

As laws and regulations regarding cannabis and hemp evolve in different
jurisdictions, we are actively seeking to expand our operations around the
world.


 


AUSTRALIA & NEW ZEALAND


TILRAY WAS THE FIRST COMPANY TO LEGALLY EXPORT MEDICAL CANNABIS FROM NORTH
AMERICA TO AUSTRALIA AND NEW ZEALAND. TODAY, TILRAY IS ONE OF THE LEADING
PROVIDERS OF MEDICAL CANNABIS IN AUSTRALIA AND NEW ZEALAND FOR COMMERCIAL,
COMPASSIONATE ACCESS AND RESEARCH PURPOSES.
 

VISIT TILRAY AUSTRALIA & NEW ZEALAND


CANADA
 


TILRAY WAS ONE OF THE FIRST COMPANIES TO BE LICENSED TO PRODUCE MEDICAL CANNABIS
IN CANADA. TODAY, TILRAY IS THE COUNTRY'S LEADING SCIENTIFICALLY RIGOROUS
PROVIDER OF MEDICAL CANNABIS, SUPPLYING TENS OF THOUSANDS OF PATIENTS IN EVERY
PROVINCE WITH CONSISTENT ACCESS TO WHOLE FLOWER, MILLED BLENDS AND OILS.

 

VISIT TILRAY CANADA


EUROPE



TILRAY WAS THE FIRST COMPANY TO LEGALLY EXPORT MEDICAL CANNABIS PRODUCTS FROM
NORTH AMERICA TO EUROPE. TILRAY ALSO HAS A CULTIVATION LICENSE FROM THE
GOVERNMENT OF PORTUGAL TO PRODUCE PRODUCTS FOR THE EU MARKET. TILRAY PRODUCTS
ARE CURRENTLY AVAILABLE AT PHARMACIES IN COUNTRIES THROUGHOUT THE EU.

Visit Tilray EU


LATIN
AMERICA


TILRAY LATIN AMERICA IMPORTS, PRODUCES AND DISTRIBUTES TILRAY BRANDED MEDICAL
CANNABIS PRODUCTS IN CHILE. TILRAY LATIN AMERICA WILL ACT AS A HUB TO DISTRIBUTE
TILRAY PRODUCTS THROUGHOUT LATIN AMERICA, STRENGTHENING THE COMPANY’S PRESENCE
IN THE REGION.

Visit Tilray Latin America


LEADERSHIP

Irwin D. Simon, Chairman and CEO
Carl Merton, Chief Financial Officer
Denise Faltischek, Chief Strategy Officer and Head of International
Jim Meiers, Chief Operations Officer
Lloyd Brathwaite, Chief Information Officer
Berrin Noorata, Chief Corporate Affairs Officer
Jared Simon, President, Manitoba Harvest and Tilray Wellness
Mitchell Gendel, Global General Counsel and Corporate Secretary
Blair MacNeil, President, Canada
Bryan Nolt, Founder and CEO, Breckenridge Distillery
Roger Savell, Chief Administrative Officer
Nyree Pinto, Chief Human Resources Officer



BOARD OF DIRECTORS

Irwin D. Simon
Renah Persofsky, ICD.D
Jodi Butts
David Clanachan
John M. Herhalt
David Hopkinson
Tom Looney


IRWIN D. SIMON, CHAIRMAN OF THE BOARD OF DIRECTORS

An executive with over 30 years of experience building industry-leading,
disruptive consumer packaged goods companies from organic and natural foods,
dietary supplements, personal care, and cannabis. Before Tilray, Mr. Simon
transformed Aphria Inc. into a profitable global cannabis company with leading
market share brands.  Mr. Simon founded The Hain Celestial Group, Inc. (NASDAQ:
HAIN), a leading organic and natural products company, in 1993.  As Founder,
President, Chief Executive Officer, and Chairman, he led Hain Celestial for more
than 25 years and grew the business to $3 billion in net sales with operations
in North America, Europe, Asia, and the Middle East, providing consumers with A
Healthier Way of Life™.  He is also the Executive Chairman of Whole Earth
Brands, Inc. (NASDAQ: FREE), a global industry-leading platform focused on the
“better for you” consumer packaged goods and ingredients space, and Presiding
Director at MDC Partners Inc., a provider of marketing, activation and
communications solutions and services. 

Mr. Simon serves on the board of directors at Tulane University and the Board of
Trustees at Poly Prep Country Day School.   A true entrepreneur, Mr. Simon is
also the majority owner of the Cape Breton Screaming Eagles, a Quebec Major
Junior Hockey League team, and co-owner of St. John’s Edge of the National
Basketball League of Canada. 


RENAH PERSOFSKY , ICD.D, VICE-CHAIR (LEAD DIRECTOR) AND CHAIR OF THE NOMINATING
AND GOVERNANCE COMMITTEE, INDEPENDENT DIRECTOR

Renah Persofsky has over 40 years of business experience. She presently serves
as the Board Chair for BookJane, an innovative technology platform that enhances
the opportunity of the gig economy in the healthcare space, and as the executive
Chair of Green Gruff, a dog wellness company that produces organic and
sustainable dog supplements. Renah also serves on the board of Hydrofarm
Holdings Group, Inc. America’s oldest and largest independent wholesaler and
manufacturer of hydroponics equipment and grow lights. Recently, Renah was
appointed to the board of Alkemy, the world’s first plastic mining company. She
has been an executive consultant to many iconic brands including Tim Hortons,
Canadian Tire, CIBC, Canada Post and Interac, and was an executive officer of
the Bank of Montreal. Ms. Persofsky is a global leader in e-commerce and has
co-chaired the Canadian Minister’s Advisory Committee on Electronic Commerce, as
well as served as a special advisor to the Minister of Foreign Affairs and
Trade.


JODI BUTTS, NOMINATING & GOVERNANCE COMMITTEE MEMBER, INDEPENDENT DIRECTOR

A lawyer by trade and an entrepreneur at heart, Jodi L.H. Butts is a
mission-oriented executive with a strong track record in driving positive change
and growth within leading organizations. Previously, Ms. Butts served as Chief
Executive Officer of Rise Asset Development and Senior Vice-President of
Operations and Redevelopment at Mount Sinai Hospital. Ms. Butts brings
significant governance experience as she currently serves as an independent
member of the Board of Directors of Canada Goose Inc.; a member of the Board of
Directors of Dot Health; a member of the Board of Governors and Audit Committee
of the University of Windsor; and Chair of the Walrus Foundation Board of
Directors. She also holds several advisory roles including with Bayshore Home
Healthcare and the Canadian Centre for the Purpose of the Corporation.


DAVID CLANACHAN, AUDIT COMMITTEE MEMBER, INDEPENDENT DIRECTOR

David F. Clanachan is Commissioner of the Canadian Premier League, a post he has
held since 2018. Mr. Clanachan was also the Chairman of Restaurant Brands
International, Canada until 2018. He was named President and Chief Operating
Officer of Tim Hortons in 2014, and had more than 35 years with the brand. Mr.
Clanachan holds a Bachelor of Commerce degree from the University of Windsor.
Mr. Clanachan brings to the Board significant experience in consumer products
and services, as well as financial, international growth, and general management
experience.




JOHN M. HERHALT CHAIR OF THE AUDIT COMMITTEE, INDEPENDENT DIRECTOR

John M. Herhalt is a FCPA (FCA) and a retired partner from KPMG and has over 40
years of experience. He has worked across several industry sectors including
automotive manufacturing, consumer products, infrastructure, power and
utilities, and the public sector. During his time with KPMG, Mr. Herhalt served
as Canada’s national advisory leader, national public sector leader, and KPMG
International’s global head of infrastructure, government, and health care
sectors providing subject matter advice and support to various KPMG member firms
and their clients on a variety of projects in the Americas, Europe, Middle East,
and Asia. After retiring from KPMG, Mr. Herhalt has continued to provide
management consulting services on a part-time basis and serves as a director on
several boards.


DAVID HOPKINSON, NOMINATING AND GOVERNANCE COMMITTEE & COMPENSATION COMMITTEE
MEMBER, INDEPENDENT DIRECTOR

An accomplished executive with more than 25 years of diverse sports industry
experience, Mr. Hopkinson is Executive Vice President of Madison Square Garden
Sports and President of Team Business Operations for MSG’s portfolio of teams
which include the New York Knicks (NBA), New York Rangers (NHL) and esports
businesses Counter Logic Gaming and Knicks Gaming. Prior to joining MSG Sports,
David served as Global Head of Partnerships for Real Madrid Club de Futbol in
Madrid, Spain from 2018 to 2020. Mr. Hopkinson spent over 20 years with Maple
Leaf Sports and Entertainment (MLSE) in Toronto, Canada and in his last role
with MLSE, he served as Chief Commercial Officer, responsible for all revenue
generation across MLSE’s teams; the Toronto Maple Leafs (NHL), Toronto Raptors
(NBA) and Toronto FC (MLS). David has served on the Chancellor’s Advisory
Committee at McGill University in Montreal, Canada as well as the Board of
Directors of Canada Basketball and Board of Directors of Canada’s Walk of Fame.
In 2013, he was awarded the Queen Elizabeth II Diamond Jubilee Medal in
recognition of his Service to Canada.


TOM LOONEY, AUDIT COMMITTEE & COMPENSATION COMMITTEE MEMBER, INDEPENDENT
DIRECTOR

Tom Looney is the former President of Diageo US Spirits & Canada. In this
position Mr. Looney maintained full responsibility for the growth and
development of the company’s spirits business in the United States & Canada
including brands such as Smirnoff, Crown Royal, Baileys, Johnnie Walker, Captain
Morgan, and Ketel One. Mr. Looney was also a member of Diageo’s North American
Executive Team. Previously, Mr. Looney held the position of President, Diageo
Beer Company overseeing US sales, finance, marketing, and innovation teams.




TILRAY NEWS

Company News

Dec 6, 2022

Good Supply Cannabis Brand Launches ‘Peppermint Phatty’
Dec 6, 2022

Dec 6, 2022

Nov 18, 2022

Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical
Cannabis Resources
Nov 18, 2022

Nov 18, 2022

Nov 10, 2022

‘Potently Canadian' Cannabis Brand, CANACA, Launches New Products and
#FeelTheBoost Campaign
Nov 10, 2022

Nov 10, 2022

Nov 7, 2022

Tilray Brands Acquires Montauk Brewing Company
Nov 7, 2022


Tilray Expands and Strengthens U.S. Footprint with Acquisition of the Fastest
Growing Craft Beer Brand and #1 Craft Brewer in Metro New York.

Nov 7, 2022

Nov 3, 2022

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Tilray
Stockholders Vote “FOR” Tilray’s Proposal to Protect Stockholders and Promote
Accountability
Nov 3, 2022


Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading
global cannabis-lifestyle and consumer packaged goods company, today announced
that Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass
Lewis), both leading independent providers of proxy research and vote
recommendations to the investment community, have recommended that Tilray
stockholders vote “FOR” Proposal 3, the Company’s proposal to eliminate Tilray’s
Class 1 common stock at the Company’s Annual Meeting of Stockholders (the
“Annual Meeting”) to be held on November 22, 2022.

Nov 3, 2022

Nov 1, 2022

Tilray Brands and Charlotte's Web Announce Strategic Alliance in Canada
Nov 1, 2022


Tilray Brands, Inc. (“Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a
leading global cannabis-lifestyle and consumer packaged goods company inspiring
and empowering the worldwide community to live their very best life, and
Charlotte’s Web Holdings, Inc. (“Charlotte’s Web”) (TSX:CWEB, OTCQX:CWBHF), the
U.S. market leader in cannabidiol (“CBD”) hemp extract wellness products, have
entered into a strategic alliance which includes licensing, manufacturing,
quality, marketing and distribution for Charlotte’s WebTM CBD hemp extract
products in Canada.

Nov 1, 2022

SEE MORE UPDATES
 


TILRAY IN THE PRESS

Featured

Nov 29, 2022

Tilray Brands Add Montauk Brewing Company To Its Growing Beverage Roster
Nov 29, 2022

Nov 29, 2022

Nov 7, 2022

Tilray to Acquire Montauk Brewing
Nov 7, 2022

Nov 7, 2022

Oct 7, 2022

Tilray CEO Irwin Simon: Cannabis world needs regulation to get institutional
money
Oct 7, 2022

Oct 7, 2022

Oct 7, 2022

Tilray CEO Irwin Simon reacts to President Biden marijuana pardons
Oct 7, 2022

Oct 7, 2022

Oct 6, 2022

Breckenridge Distillery Releases Two New Broncos Bourbon Blends
Oct 6, 2022

Oct 6, 2022

Jul 21, 2022

If cannabis isn't legalized, companies will continue to consolidate, says Tilray
CEO Irwin Simon
Jul 21, 2022

Jul 21, 2022

SEE MORE NEWS


VIDEOS

 
 



CONTACT

Business development
EXPORT OPPORTUNITIES
RESEARCH PARTNERSHIPS
Media Requests
CAREER OPPORTUNITIES
INVESTOR RELATIONS
 

Back to Top
Terms of Use
Privacy Policy
 

© 2022 Tilray. All Rights Reserved